Qualitative Study of Treatment Preferences for Rheumatoid Arthritis and Pharmacotherapy Acceptance: Indigenous Patient Perspectives

Adalberto Loyola-Sanchez, Glen Hazlewood, Lynden Crowshoe, Tessa Linkert, Pauline M Hull, Deborah Marshall, Cheryl Barnabe, Adalberto Loyola-Sanchez, Glen Hazlewood, Lynden Crowshoe, Tessa Linkert, Pauline M Hull, Deborah Marshall, Cheryl Barnabe

Abstract

Objective: To explore patient preferences that influence decision-making in the management of rheumatoid arthritis (RA) by indigenous patients living in southern Alberta, Canada.

Methods: We conducted a qualitative narrative-based study within a social constructivist framework. Thirteen in-depth interviews with indigenous patients with RA who had attended 1 of 3 rheumatology practices in southern Alberta (1 rural and 2 urban) were completed. Codes generated through 2 phases of analysis were condensed into main themes, triangulated, and used to produce theoretical statements.

Results: Patients preferred to use a combination of nonpharmacologic and pharmacologic treatments to manage their RA. Nonpharmacologic treatments included physical, mental, emotional, and spiritual strategies. Patients' preferences for taking medications varied and were influenced by factors that were clinical (i.e., trust in health providers and understanding drugs' mechanisms of action, benefits, harms, and administration burden), familial (i.e., support), and societal (i.e., access to medications and stigmatization of drug dependency).

Conclusion: Indigenous patients apply a holistic approach to the nonpharmacologic management of RA. Increases in preferences for RA medications could be supported through enhanced communication strategies to increase patient understanding of medication effects and health provider recognition of societal and familial influences on patient decisions. A patient-provider relationship based on trust was fundamental to reaching mutual understanding and should be fostered by models of practice that promote cultural safety, empathy, compassion, openness, acknowledgment, and respect of cultural differences.

© 2019, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

Figures

Figure 1
Figure 1
Heuristic model describing how health providers could increase medication acceptance in the clinical setting.

References

    1. Barnabe C, Jones CA, Bernatsky S, Peschken CA, Voaklander D, Homik J, et al. Inflammatory arthritis prevalence and health services use in the first nations and non‐first nations populations of Alberta, Canada. Arthritis Care Res (Hoboken) 2017;69:467–74.
    1. Thurston WE, Coupal S, Jones CA, Crowshoe LF, Marshall DA, Homik J, et al. Discordant indigenous and provider frames explain challenges in improving access to arthritis care: a qualitative study using constructivist grounded theory. Int J Equity Health 2014;13:46.
    1. Barnabe C, Healy B, Portolesi A, Kaplan GG, Hemmelgarn B, Weaselhead C. Claims for disease‐modifying therapy by Alberta non‐insured health benefits clients. BMC Health Serv Res 2016;16:430.
    1. Nagaraj S, Kargard M, Hemmelgarn B, Fritzler M, White T, Barnabe C. Effectiveness of an outreach model of care for rheumatology specialty clinics to and on‐reserve first nations community. Int J Indig Health 2018;13:157–67.
    1. Barnabe C, Zheng Y, Ohinmaa A, Crane L, White T, Hemmelgarn B, et al. Effectiveness, complications, and costs of rheumatoid arthritis treatment with biologics in Alberta: experience of indigenous and non‐indigenous patients. J Rheumatol 2018;45:1344–52.
    1. Spiro AP, A. A holistic approach to health care can lower costs and improve quality. Hospitals and Health Networks Magazine; 2016. URL: .
    1. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ 2002;325:961–4.
    1. Constantinescu F, Goucher S, Weinstein A, Fraenkel L. Racial disparities in treatment preferences for rheumatoid arthritis. Med Care 2009;47:350–5.
    1. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice‐format survey. Value Health 2007;10:415–30.
    1. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease‐modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492–509.
    1. Berger PL, Luckmann T. Society as subjective reality In: The social construction of reality a treatise in the sociology of knowledge. New York, NY: Anchor Books; 1966. p. 173–80.
    1. Denzin KNL, Y.S. Part IV: Methods of collecting and analyzing empirical materials In: Denzin KNL, Y.S., editor. The sage handbook of qualitative research. 3rd ed London: Sage Publications; 2005. p. 641–2.
    1. First Nations Market Housing Fund . Siksika Nation; 2017. URL: .
    1. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health 2015;42:533–44.
    1. Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 2018;52:1893–1907.
    1. Ethics in First Nations research . [Ottawa, Ont.]: Assembly of First Nations, Environmental Stewardship Unit; 2009. URL:
    1. Chapter 9. Research involving the First Nations, Inuit and Métis Peoples of Canada In: Tri‐council policy statement ethical conduct for research involving humans. 2nd ed Ottawa, Ontario: Interagency Secretariat on Research Ethics; 2010. URL:
    1. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277–88.
    1. Kleinman A. Orientations 2: Culture, health care systems, and clinical reality In: Leslie C, editor. Patients and healers in the context of culture. 1. London, UK: University of California Press; 1980. p. 24–70.
    1. Strickland CJ. The importance of qualitative research in addressing cultural relevance: experiences from research with Pacific Northwest Indian women. Health Care Women Int 1999;20:517–25.
    1. Engel GL. The need for a new medical model: a challenge for biomedicine. Psychodyn Psychiatry 2012;40:377–96.
    1. Rix EF, Wilson S, Sheehan N, Tujague N. Indigenist and decolonizing research methodology In: Liamputtong P, editor. Handbook of research methods in health social sciences. Singapore: Springer Singapore; 2018. p. 1–15.
    1. Zhang Y, Baik SH. Race/ethnicity, disability, and medication adherence among Medicare beneficiaries with heart failure. J Gen Intern Med 2014;29:602–7.
    1. Jimenez N, Garroutte E, Kundu A, Morales L, Buchwald D. A review of the experience, epidemiology, and management of pain among American Indian, Alaska Native, and Aboriginal Canadian peoples. J Pain 2011;12:511–22.
    1. Juarez DT, Tan C, Davis JW, Mau MM. Using quantile regression to assess disparities in medication adherence. Am J Health Behav 2014;38:53–62.
    1. Ferucci ED, Schumacher MC, Lanier AP, Murtaugh MA, Edwards S, Helzer LJ, et al. Arthritis prevalence and associations in American Indian and Alaska Native people. Arthritis Rheum 2008;59:1128–36.
    1. Truth, Reconciliation Commission of Canada . Honouring the truth, reconciling for the future: summary of the final report of the Truth and Reconciliation Commission of Canada. S.l.: Truth and Reconciliation Commission of Canada; 2015. URL: .
    1. Kumar K, Raza K, Nightingale P, Horne R, Chapman S, Greenfield S, et al. Determinants of adherence to disease modifying anti‐rheumatic drugs in white British and South Asian patients with rheumatoid arthritis: a cross sectional study. BMC Musculoskelet Disord 2015;16:396.
    1. Morgan C, McBeth J, Cordingley L, Watson K, Hyrich KL, Symmons DP, et al. The influence of behavioral and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology (Oxford) 2015;54:1780–91.
    1. Kelly A, Tymms K, Tunnicliffe DJ, Sumpton D, Perera C, Fallon K, et al. Patients’ attitudes and experiences of disease‐modifying anti‐rheumatic drugs in rheumatoid arthritis and spondyloarthritis: a qualitative synthesis. Arthritis Care Res (Hoboken) 2018;70:525–32.
    1. Bell RA, Arcury TA, Ip E, Grzywacz JG, Nguyen H, Kirk JK, et al. Correlates of physician trust among rural older adults with diabetes. Am J Health Behav 2013;37:660–6.
    1. Muller R, Kallikorm R, Polluste K, Lember M. Compliance with treatment of rheumatoid arthritis. Rheumatol Int 2012;32:3131–5.
    1. Stacey D, Kryworuchko J, Belkora J, Davison BJ, Durand MA, Eden KB, et al. Coaching and guidance with patient decision aids: a review of theoretical and empirical evidence. BMC Med Inform Decis Mak 2013;13:S11.
    1. Jull J, Giles A, Boyer Y, Stacey D. Cultural adaptation of a shared decision making tool with Aboriginal women: a qualitative study. BMC Med Inform Decis Mak 2015;15:1.
    1. Crowshoe LL, Han H, Calam B, Henderson R, Jacklin K, Walker L, et al. Impacts of educating for equity workshop on addressing social barriers of type 2 diabetes with indigenous patients. J Contin Educ Health Prof 2018;38:49–59.
    1. Gadallah MA, Boulos DNK, Gebrel A, Dewedar S, Morisky DE. Assessment of rheumatoid arthritis patients’ adherence to treatment. Am J Med Sci 2015;349:151–6.
    1. Pascual‐Ramos V, Contreras‐Yanez I. Motivations for inadequate persistence with disease modifying anti‐rheumatic drugs in early rheumatoid arthritis: the patient's perspective. BMC Musculoskelet Disord 2013;14:336.
    1. Solomon DH, Tonner C, Lu B, Kim SC, Ayanian JZ, Brookhart MA, et al. Predictors of stopping and starting disease‐modifying antirheumatic drugs for rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66:1152–8.
    1. Milne V, Kearns R, Harrison A. Patient age, ethnicity and waiting times determine the likelihood of non‐attendance at a first specialist rheumatology assessment. Int J Rheum Dis 2014;17:19–25.
    1. McKenzie HA, Dell CA, Fornssler B. Understanding addictions among indigenous people through social determinants of health frameworks and strength‐based approaches: a review of the research literature from 2013 to 2016. Curr Addict Rep 2016;3:378–86.
    1. Farmer P. An anthropology of structural violence. Curr Anthropol 2004;45:305–25.
    1. Shahram S. The social determinants of substance use for aboriginal women: a systematic review. Women Health 2016;56:157–76.
    1. Greenwood M, De Leeuw S, Lindsay NM, Reading C. Determinants of indigenous peoples’ health in Canada: beyond the social. Toronto: Canadian Scholars’ Press; 2015.
    1. Bartlett C, Marshall M, Marshall A. Two‐eyed seeing and other lessons learned within a co‐learning journey of bringing together indigenous and mainstream knowledges and ways of knowing. J Environ Stud Sci 2012;2:331–40.
    1. Hitziger M, Gonzalez MB, Gharzouzi E, Santizo DO, Miranda RS, Ferro AIA, et al. Patient‐centered boundary mechanisms to foster intercultural partnerships in health care: a case study in Guatemala. J Ethnobiol Ethnomed 2017;13:44.
    1. Yeung S. Conceptualizing cultural safety: definitions and applications of safety in health care for indigenous mothers in Canada. J Soc Thought 2016;1 URL: .

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit